Radiation Therapy Combined With Paclitaxel and Carboplatin in Treating Patients With Stage III Non-Small Cell Lung Cancer
Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in
chemotherapy, such as paclitaxel and carboplatin, work in different ways to stop tumor cells
from dividing so they stop growing or die. Combining more than one drug and giving them with
specialized radiation therapy may kill more tumor cells.
PURPOSE: This phase I/II trial is studying the effectiveness of radiation therapy combined
with paclitaxel and carboplatin in treating patients who have stage III non-small cell lung
cancer.